After her young boy contracted a fever, Nusralati, 29, gave him a medicinal syrup.
But quickly, the child coughs, vomits and no longer urinates.
“Once in the hospital, the situation worsened because he was not urinating at all.
But the doctors didn't know why,” says the mother, originally from Aceh, a province in the north of the island of Sumatra.
An ultrasound performed at another hospital shows that the baby's kidney has stopped producing urine.
Three days after his hospitalization, he will die.
Their tragedy comes as Indonesian authorities have been investigating for several weeks the cause of a worrying wave of cases of acute kidney injury (ARI) in young children across the Southeast Asian country.
Nearly 178 children have died.
Read alsoIndian cough syrups: the Gambian police in turn open an investigation after the death of 66 children
At the end of October, investigators withdrew the licenses to produce the medicinal syrups suspected of being at the origin of this wave of deaths from three local pharmaceutical companies.
They said they would take criminal action against the three companies, PT Yarindo Farmatama, PT Universal Pharmaceutical Industries and PT Afi Farma Pharmaceutical Industries, after finding that they had made changes to the ingredients of the syrups without reporting them to the authorities.
The Food and Medicines Supervisory Agency (BPOM) explained that the medicinal syrups contained a raw material that contained excessive amounts of two potentially toxic chemicals: ethylene glycol and diethylene glycol.
Both are used in commercial and industrial applications such as antifreeze.
"There is a link between the acute kidney injury that has caused the death of so many children and the consumption of syrup for children containing a high concentration of diethylene glycol and ethylene glycol", continues Penny Lukito, head of the Agency. Indonesian food and drug monitoring.
The Indonesian government also announced a temporary ban on the use of the suspected syrups during the investigation.